Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.
Menopause District I ACOG Medical Student Education Module 2009 Source:  UpToDate
Overview of Presentation <ul><li>Definition </li></ul><ul><li>Etiology/Endocrinology </li></ul><ul><li>Epidemiology </li><...
Etiology/Endocrinology <ul><li>Menopause occurs due to programmed loss of ovarian follicles </li></ul><ul><li>During perim...
Definition <ul><li>Stages of Reproductive Aging Workshop ( STRAW) Staging System 2001 </li></ul><ul><li>Menopausal transit...
Epidemiology <ul><li>Average age of menopause is app. 51.4 years; menopause prior to age 40 is premature ovarian failure <...
Clinical Manifestations <ul><li>Irregular bleeding patterns - if heavy bleeding should perform endometrial surveillance gi...
Clinical Manifestations-2 <ul><li>Vaginal dryness  – Estrogen deficiency leads to thinning of epithelium - > vaginal atrop...
Clinical Manifestations -3 <ul><li>Depression  – Overall studies support an association between menopause and mood changes...
Therapies <ul><li>Tx moderate/severe vasomotor sx only </li></ul><ul><li>Estrogen  – most effective; po or transdermal; if...
Therapies -2 <ul><li>Progestins  – Megestrol acetate, norethindrone acetate, high dose DMPA shown to be effective </li></u...
Upcoming SlideShare
Loading in …5
×

Menopause

1,025 views

Published on

  • Be the first to comment

Menopause

  1. 1. Menopause District I ACOG Medical Student Education Module 2009 Source: UpToDate
  2. 2. Overview of Presentation <ul><li>Definition </li></ul><ul><li>Etiology/Endocrinology </li></ul><ul><li>Epidemiology </li></ul><ul><li>Clinical Manifestations </li></ul><ul><li>Diagnosis </li></ul><ul><li>Therapies </li></ul>
  3. 3. Etiology/Endocrinology <ul><li>Menopause occurs due to programmed loss of ovarian follicles </li></ul><ul><li>During perimenopause inhibin B falls due to decline in follicular number and FSH rises, estradiol preserved, low progesterone </li></ul><ul><li>In late menopausal transition, FSH and estradiol fluctuate </li></ul><ul><li>After menopause, ovary no longer secretes estradiol, however produces androgens under the stimulation of LH </li></ul>
  4. 4. Definition <ul><li>Stages of Reproductive Aging Workshop ( STRAW) Staging System 2001 </li></ul><ul><li>Menopausal transition: a) Variation in menstrual cycle ( > 7 d different from normal) and ≥2 skipped cycles and >=60 d amenorrhea; b)  FSH </li></ul><ul><li>Perimenopause: Starts at the time of the menopausal transition ( see above) and ends 12 months after last menstrual period </li></ul><ul><li>Menopause: 12 months of amenorrhea after final menses </li></ul><ul><li>Postmenopause: Stage 1 is the first 5 years after menopause – women have bone loss and hot flashes. Stage 2 is 5 yrs after the last menstrual period until death. </li></ul>
  5. 5. Epidemiology <ul><li>Average age of menopause is app. 51.4 years; menopause prior to age 40 is premature ovarian failure </li></ul><ul><li>Age of menopause reduced in smokers </li></ul><ul><li>Ethnicity and race may influence menopause, earlier age among Hispanic women and later in Japanese-American women when c/w Caucasian </li></ul><ul><li>Important to assess family history of early menopause </li></ul>
  6. 6. Clinical Manifestations <ul><li>Irregular bleeding patterns - if heavy bleeding should perform endometrial surveillance given period of unopposed estrogen exposure </li></ul><ul><li>Hot flashes - Etiology unknown. Thermoregulatory dysfunction. Self limited to 1-5 yrs. Variable among cultures – 75% US women complain of hot flashes, 20% seek therapy. </li></ul><ul><li>Sleep disturbance – Hot flashes can arouse from sleep and primary sleep disorders more common </li></ul>
  7. 7. Clinical Manifestations-2 <ul><li>Vaginal dryness – Estrogen deficiency leads to thinning of epithelium - > vaginal atrophy ( loss of rugae, pale, pH inc to > 6.0) </li></ul><ul><li>Sexual dysfunction – decrease in blood flow to vagina/vulva -> decreased lubrication; dyspareunia </li></ul><ul><li>Urinary sx – low estrogen results in atrophy of urethral epithelium and predispose to stress/urge urinary incontinence </li></ul>
  8. 8. Clinical Manifestations -3 <ul><li>Depression – Overall studies support an association between menopause and mood changes such as irritability/nervousness; controversial if related to true depression </li></ul><ul><li>Bone loss – secondary to estrogen def </li></ul><ul><li>Breast pain – Common in early menopausal transition </li></ul><ul><li>Skin changes – estrogen def -> reduced collagen content of the skin/bones </li></ul>
  9. 9. Therapies <ul><li>Tx moderate/severe vasomotor sx only </li></ul><ul><li>Estrogen – most effective; po or transdermal; if women has uterus give in conjunction with progesterone; short term therapy; taper to end </li></ul><ul><li>Behavioral changes – keeping temp cool, regular exercise, relaxation therapy </li></ul><ul><li>SSRIs – One of first choices if not taking HRT. RCT’s have shown benefit </li></ul><ul><li>Gabapentin - suggested for nocturnal hot flashes </li></ul>
  10. 10. Therapies -2 <ul><li>Progestins – Megestrol acetate, norethindrone acetate, high dose DMPA shown to be effective </li></ul><ul><li>Clonidine – effective in some trials; try transdermal; may be good in women with HTN </li></ul><ul><li>Phytoestrogens – NO more effective than placebo; concern is that they are SERMS </li></ul><ul><li>Herbal/Black Cohosh – No more effective than placebo; may have estrogenic effect on breast </li></ul>

×